|
|
||||||||
Articles |
Departments of
1
Pathology and Laboratory Medicine, and
2
Medical Oncology, University Hospital Groningen, 9700 RB Groningen, The Netherlands.
3
Spark Holland B.V., 7800 AJ Emmen, The Netherlands.
aAddress correspondence to this author at: Department of Pathology and Laboratory Medicine, University Hospital Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands. Fax 31-50-6612290; e-mail i.p.kema{at}lab.azg.nl.
Background: Profiling of the plasma indoles tryptophan, 5-hydroxytryptophan (5-HTP), serotonin, and 5-hydroxyindoleacetic acid (5-HIAA) is useful in the diagnosis and follow-up of patients with carcinoid tumors. We describe an automated method for the profiling of these indoles in protein-containing matrices as well as the plasma indole concentrations in healthy controls and patients with carcinoid tumors.
Methods: Plasma, cerebrospinal fluid, and tissue homogenates were prepurified by automated on-line solid-phase extraction (SPE) in Hysphere Resin SH SPE cartridges containing strong hydrophobic polystyrene resin. Analytes were eluted from the SPE cartridge by column switching. Subsequent separation and detection were performed by reversed-phase HPLC combined with fluorometric detection in a total cycle time of 20 min. We obtained samples from 14 healthy controls and 17 patients with metastasized midgut carcinoid tumors for plasma indole analysis. In the patient group, urinary excretion of 5-HIAA and serotonin was compared with concentrations of plasma indoles.
Results: Within- and between-series CVs for indoles in platelet-rich plasma were 0.66.2% and 3.712%, respectively. Results for platelet-rich plasma serotonin compared favorably with those obtained by single-component analysis. Plasma 5-HIAA, but not 5-HTP was detectable in 8 of 17 patients with carcinoid tumors. In the patient group, platelet-rich plasma total tryptophan correlated negatively with platelet-rich plasma serotonin (P = 0.021; r = -0.56), urinary 5-HIAA (P = 0.003; r = -0.68), and urinary serotonin (P <0.0001; r = -0.80).
Conclusions: The present chromatographic approach reduces analytical variation and time needed for analysis and gives more detailed information about metabolic deviations in indole metabolism than do manual, single-component analyses.
The following articles in journals at HighWire Press have cited this article:
![]() |
K. P. Koopmans, O. C. Neels, I. P. Kema, P. H. Elsinga, W. J. Sluiter, K. Vanghillewe, A. H. Brouwers, P. L. Jager, and E. G.E. de Vries Improved Staging of Patients With Carcinoid and Islet Cell Tumors With 18F-Dihydroxy-Phenyl-Alanine and 11C-5-Hydroxy-Tryptophan Positron Emission Tomography J. Clin. Oncol., March 20, 2008; 26(9): 1489 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zolkowska, M. H. Baumann, and R. B. Rothman Chronic Fenfluramine Administration Increases Plasma Serotonin (5-Hydroxytryptamine) to Nontoxic Levels J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 791 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H.A. de Jong, K. S. Graham, J. C. van der Molen, T. P. Links, M. R. Morris, H. A. Ross, E. G.E. de Vries, and I. P. Kema Plasma Free Metanephrine Measurement Using Automated Online Solid-Phase Extraction HPLC Tandem Mass Spectrometry Clin. Chem., September 1, 2007; 53(9): 1684 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Russo, I. P. Kema, E. B. Haagsma, J. C. Boon, P. H.B. Willemse, J. A. den Boer, E. G.E. de Vries, and J. Korf Irritability Rather Than Depression During Interferon Treatment Is Linked to Increased Tryptophan Catabolism Psychosom Med, September 1, 2005; 67(5): 773 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Mulder, A. Oosterloo-Duinkerken, G. M. Anderson, E. G.E. De Vries, R. B. Minderaa, and I. P. Kema Automated On-Line Solid-Phase Extraction Coupled with HPLC for Measurement of 5-Hydroxyindole-3-acetic Acid in Urine Clin. Chem., September 1, 2005; 51(9): 1698 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Schulpis, G. A. Karikas, J. Tjamouranis, H. Michelakakis, and S. Tsakiris Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria Clin. Chem., October 1, 2002; 48(10): 1794 - 1796. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |